With talk about the sell-off of Thermo Fisher Scientific’s TMO shares by institutional investors and company insiders, market sentiment toward the company seems bearish. The stock has lost 12.7% in the...
While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.
MARC N CASPER, the Chairman & CEO of $TMO ($TMO), sold 759 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.7% of their shares....
Losses for big technology stocks pulled major indexes lower on Wall Street
Despite Thermo Fisher Scientific’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.
For Immediate ReleaseChicago, IL – November 19, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...
Monday, November 18, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher...
The S&P 500 Index ($SPX ) (SPY ) on Wednesday fell by -0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) fell by -0.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) fell by -1.59%. Stocks on Wednesday...
TMO earnings call for the period ending September 30, 2024.
The S&P 500 Index ($SPX ) (SPY ) today is down by -0.35%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.51%. Stocks today are...